Ebola survivor Dr. Rick Sacra to return to West Africa

Rick Sacra, MD, an American Ebola survivor, plans to return to work in Liberia — the country where he contracted Ebola — on Jan. 15.

Advertisement

Dr. Sacra was the third American with Ebola to be treated in the U.S. He received treatment at The Nebraska Medical Center in Omaha, where he was airlifted in September 2014. He eventually beat the deadly virus and was discharged later that month.

During his return trip to Liberia, Dr. Sacra will treat patients who have malaria and chronic health issues, not Ebola patients, even though physicians have said he is now immune to the virus. He will be in Liberia for about three weeks.

See Dr. Sacra’s press conference here, via ABC News.

Dr. Sacra’s trip to Liberia will put him in the heart of the worst Ebola outbreak in history. According to the Centers for Disease Control and Prevention, Ebola has killed 8,371 people in West Africa as of Jan. 10, and 3,515 of those deaths occurred in Liberia.

More articles on Ebola:
US now has 48 Ebola treatment centers
Experimental Ebola vaccine by Johnson & Johnson begins trials
Nebraska Medical Center takes possible Ebola patient

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.